Daniel M. Halperin MD

Daniel M. Halperin, MD, is a board-certified medical oncologist, specializes in the treatment of neuroendocrine tumors (NETs). Dr. Halperin is a physician on the gastrointestinal oncology team at Winship Cancer Institute of Emory University. Dr. Halperin is an associate professor and serves as vice chair for clinical affairs in the Department of Hematology and Medical Oncology at Emory University School of Medicine. As vice chair of clinical affairs, he works with the department chair and other leaders to plan, communicate, and execute Winship strategies and organizational goals in the clinical arena, and to support and direct the performance of physician faculty members in the department.

Dr. Halperin received his medical degree from Weill Cornell Medical College in New York City, New York. He completed his internal medicine residency at Brigham and Women's Hospital in Boston, Massachusetts, and his medical oncology training at the University of Texas MD Anderson Cancer Center in Houston, Texas. As a clinical investigator, Halperin is dedicated to providing world-class clinical care and developing novel therapies for patients with neuroendocrine tumors (NETs), which are tumors that develop from a diffuse network of neuroendocrine cells that make and release hormones into the bloodstream to control essential bodily functions. He has played a leading role in clinical trials of immunotherapy and radioligands for patients with NETs. He also collaborates with laboratory and population scientists to deepen our understanding of the molecular basis and clinical presentation of neuroendocrine tumors.